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Background: The prevalence of postoperative wound infection in patients with neuromuscular scoliosis surgery
is significantly higher than that in patients with other spinal surgery. Hyperbaric oxygen has been used as a
supplement to treat postsurgical infections. Our aim was to determine beneficiary effects of hyperbaric oxygen
treatment in terms of prevention of postoperative deep infection in this specific group of patients in a retrospective
study.
Methods: Forty two neuromuscular scoliosis cases, operated between 2006–2011 were retrospectively reviewed.
Patients who had presence of scoliosis and/or kyphosis in addition to cerebral palsy or myelomeningocele,
postoperative follow-up >1 year and posterior only surgery were the subjects of this study. Eighteen patients
formed the Hyperbaric oxygen prophylaxis (P-HBO) group and 24, the control group. The P-HBO group received
30 sessions of HBO and standard antibiotic prophylaxis postoperative, and the control group (received standard
antibiotic prophylaxis).
Results: In the P-HBO group of 18 patients, the etiology was cerebral palsy in 13 and myelomeningocele in 5 cases
with a mean age of 16.7 (11–27 yrs). The average follow-up was 20.4 months (12–36mo). The etiology of patients in
the control group was cerebral palsy in 17, and myelomeningocele in 7 cases. The average age was 15.3 years
(8–32 yrs). The average follow-up was 38.7 months (18–66mo). The overall incidence of infection in the whole study
group was 11.9% (5/42). The infection rate in the P-HBO and the control group were 5.5% (1/18), and 16.6% (4/24)
respectively. The use of HBO was found to significantly decrease the incidence of postoperative infections in
neuromuscular scoliosis patients.
Conclusion: In this study we found that hyperbaric oxygen has a possibility to reduce the rate of post-surgical
deep infections in complex spine deformity in high risk neuromuscular patients.
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The prevalence of postoperative wound infection after
scoliosis surgery is significantly higher in neuromuscular
scoliosis patients when compared to other types of sco-
liosis [1]. It may also compromise the correction ob-
tained by surgery, especially in cases in which hardware
removal is necessary. There are various factors that may
contribute to the increased risk for postoperative wound
infections in patients with neuromuscular disease. Severe
neurologic involvement, a diagnosis of myelodysplasia,* Correspondence: erkaninanmaz@yahoo.com
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unless otherwise stated.the use of allograft bone, preoperative malnutrition,
urinary tract infection, and excessive blood loss have all
been identified as potential risk factors [1-3].
Hyperbaric oxygen (HBO) has been reported to heal
postoperative spinal infections in adults with intact
osteosynthesis material [4]. HBO therapy increases oxy-
gen tension in tissues, including bone, with increased
bone-turnover and increased bone-metal contact [5].
The purpose of this retrospective study was to compare
and evaluate the infection rate of neuromuscular scoliosis
patients undergoing instrumented only-posterior spinal
fusion who were treated with or without early postopera-
tive prophylactic administration of HBO (P-HBO). We hy-
pothesized that the use of hyperbaric oxygen in additionl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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rate without adverse clinical effects.
Methods
This study was done at a university hospital. Since April
2009 patients with neuromuscular spinal deformities had
received HB0 postoperative with the aim of reducing the
incidence of postoperative infections and wound healing
problems. To determine the effect of supplemental HBO
on the infection rates in our patients, the neuromuscular
deformity cases, operated between 2006–2011, were re-
trospectively reviewed. A total of 55 patients with neu-
romuscular deformities were operated within the given
time period. The inclusion criteria were: presence of
scoliosis and/or kyphosis in addition to cerebral palsy or
myelomeningocele, postoperative follow-up >1 year and
posterior only surgery. Patients who did not meet these
criteria, or who did not have enough data in the patient
file were excluded.
We had a total of 42 patients meeting these inclusion
criteria. The reasons for exclusion of 13 cases were: pres-
ence of a neuromuscular condition other than the above
[6], anterior/posterior combined surgery [3] and insuffi-
cient data [4]. Eighteen patients formed the P-HBO group
and 24 the control group. The patients and/or their fam-
ilies were informed that their data would be submitted for
publication, and gave their informed consent which was
archived in the patients’ folders. The study was approved
by the local ethics committee of Sakarya University.
Preoperative risk factors for infection were: prior spine
surgery, degree of cognitive delay, nutritional parameters
including albumin and total lymphocyte count, and prior
urinary tract infection and decubiti. Operative time, esti-
mated blood loss (EBL), and number of levels fused were
obtained from the chart. Finally, we evaluated the post-
operative clinical parameters: infection rate, time of in-
fection, implant removal due to infection, re-operations,
pseudoarthrosis. The primary outcome evaluated was
the incidence of infection.
Deep wound infection for the purpose of this study,
and as described in the literature is defined as a surgical
site infection in which there is a communication bet-
ween the associated infected material and the spinal in-
strumentation and bone graft/fusion mass, as proven by
surgical exploration. The types of prophylactic antibiotics
used and the duration of their administration were the
same in both groups. All patients received standard sys-
temic antibiotic prophylaxis consisting of 1 g IV Cefazolin
1 hour before surgical incision and this was followed by
1 g IV Cefazolin every 8 hours for 3 days. Patients in both
groups underwent the same intraoperative technique by
the same surgeon and the same postoperative protocol.
After surgery, patients in both groups were managed
in the same manner the only difference being is theapplication of prophylactic HBO in one group starting
after surgery.
All patients in the HBO group were treated in a multi-
place hyperbaric chamber (BarOtechNEO; BarOtech®INC),
Hyperbaric (100%) oxygen was administered at a pressure
of 2.4 ATA for 90 minutes/day. Patients underwent 30 ses-
sions of treatment over a 6 weeks period (5 sessions/
week).
Results
Forty-two patients were enrolled in the study. The mean
age at the time of surgery was 15.7 years (8–32 yrs).
The average follow-up after the index procedure was
2.3 years. Thirty patients had cerebral palsy and 12 had
myelomeningocele.
In the P-HBO group of 18 patients, the etiology was
cerebral palsy in 13 and myelomeningocele in 5 cases with
a mean age of 16.7 (11–27 yrs). The average follow-up
was 20.4 months (12–36 mo). This group was routinely
administered HBO starting on postoperative second or
third day. The control group consisted of 24 patients and
the etiology was cerebral palsy in 17, myelomeningocele in
7 cases. The average age was 15.3 years (8–32 yrs). The
average follow-up was 38.7 months (18–66 mo).
One patient in each group with a stiff and severe de-
formity had undergone preoperative halo traction for
2 weeks. In 7 patients, spinal fixation was extended down
to the pelvis using iliac screws. Posterior correction was
performed using pedicular screws, intralaminar screws,
laminar hooks, sublaminar wires and rods. Only titanium
implants (Tasarım Med®INC, Istanbul, Turkey) were used
for the spinal correction. At the end of the procedure, a
mixture of autograft (harvested on spinous processes) and
allograft cancellous chips (Allograft Innovations, LLC
Gainsville, FL, USA) were placed to enhance bony fusion.
There were no significant differences between the
HBO group and the control group in terms of the num-
ber of fused levels, the amount of intraoperative blee-
ding, and the duration of operation (Table 1).
One patient in the P-HBO group had mild mental re-
tardation, as compared with two in the control group.
Four patients in the P-HBO and five in the control
group had prior back surgery (closure of meningomyelo-
cele in the newborn period). There were insufficient data
available to compare nutrition markers and previous
urinary tract infections. Three meningocele patients
had decubiti on the surgical area (Two in the P-HBO
(Figure 1) and one in the control group).
There was an overall incidence of 11.9% (5/42) of in-
fection in the whole study group. The rate of infection
was altered by the underlying diagnosis. The incidence
of infection among the patients with cerebral palsy was
10% (3/30) and the incidence of infection among the pa-
tients with myelomeningocele was 16.6% (2/12). The
Table 1 Details of unpaired t test comparison of mean study control and P-HBO groups SD: standart deviation
Groups N Mean SD t value P
FUSED LEVELS (no of vertebra) P-HBO 18 13,2 2,84 -0,613 0,544
Control 24 12,7 2,40
BLOOD LOSS (ml) P-HBO 18 1370 352 -0,614 0,543
Control 24 1280 530
SURGERY TIME (min) P-HBO 18 244,8 53,1 -0,032 0,974
Control 24 244,3 47,6
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5.5% (1/18), and 16.6% (4/24) respectively. When the in-
fection rates were compared according to the primary
diagnosis, none of the myelomeningocele patients had
infection in the P-HBO group compared to 2 (28.5%) in
the control group. The infection rates in cerebral palsy
patients were 7.6% (1/13) and 11.7% (2/17) in the
P-HBO and the control groups respectively (Table 2).
Complications were evaluated in terms of reopera-
tions, implant removal and pseudarthrosis. The average
number of reoperations was 2.8/infected patient. All pa-
tients received antibiotics according to their bacterial
cultures as advised by specialists in infectious diseases.
One patient had persistent pseudoarthrosis at the final
follow-up. No immediate or delayed adverse effects re-
lated to the use of HBO were noted.
Discussion
Despite the use of prophylactic systemic antibiotics and
improved surgical technique, surgical site infections re-
main a serious concern in neuromuscular patients. The
rate of wound infection after surgery for idiopathic
scoliosis ranges from 1% to 5%. In contrast, the rate of
infection in spinal surgery for deformity related to mye-
lomeningocele has been reported to be from 8% to 24%.
The rate of infection in spinal surgery for deformity re-
lated to cerebral palsy has been reported to be from
6.1% to 8.7%. [1-3,6,7]. The use of prophylactic HBO inFigure 1 A-14-year-old male patient with congenital kyphosis due to
showing infected skin ulcers at the apex of the deformity and patient was
day 1. Prophylactic HBO was started after surgery. d: Lateral and e: posterio
informed consent was obtained from the patient for publication of Figureneuromuscular deformity patients has been reported
twice in the literature. Kose et al. [8] used supplemental
HBO in a meningomyelocele patient who underwent
three level kyphectomy. Although the skin overlying the
kyphotic segment was infected and ulcerated before the
operation, the wound healed without any problems
postoperatively. Larrson et al. [9] used preoperative
HBO-treatment because of the calculated high risk for
infection in two patients. Both had suffered postopera-
tive infections at several previous surgical interventions,
and did so despite HBO prophylaxis. They were treated
with a prolonged HBO protocol, and eventually healed
without removal of implants. In our study, the infection
rate of 16.6% in the control group is similar to the rates
in the literature however; the infection rate of 5.5% in
the P-HBO group is significantly lower.
Hyperbaric oxygen therapy (HBOT) has been added to
treatment protocols in chronic wound problems with suc-
cessful outcomes. Dramatic beneficial effects of HBOT
were also observed in patients with spinal infections
caused by a variety of microorganisms. Ravicovitch and
Spallone [10] obtained good results for treatment of spinal
epidural abscesses with HBOT after laminectomy. Larsson
et al. [4,9] applied HBOT for the treatment of neurosur-
gical infections after cranial and spinal surgeries. These in-
vestigations have primarily focused on the treatment of
infected wounds. Recently, there has been an increasing
interest for prophylaxis against infection. For this reason,meningomyelocele. a: lateral and b: posterior view of the patient
predicted as high risk for infection c: The wound at postoperative
r clinical presentation of patient at postoperative 24th month. Written
1 images.
Table 2 Group-specific infection rates CP: cerebral palsy,
MM: myelomeningocele, Inf: infection
Total CP MM
# Inf Rate # Inf Rate # Inf Rate
P-HBO 18 1 %5,5 13 1 %7,6 5 0 %0
Control 24 4 %16,6 17 2 %11,7 7 2 %28,5
Overall 42 5 %11,9 30 3 %10 12 2 %16,6
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wounds. Bouachour et al. [11] studied HBOT in patients
with crush injuries where complete wound healing was
achieved in 17 patients (94%) treated with HBOT versus
10 patients (56%) in the sham-HBOT group, showing a
statistically significant difference in favor of HBOT. Huang
et al. [12] studied a prospective, 16 patients with complex
open elbow injuries who were treated with a combination
of treatment modalities. The treatment protocol also used
HBOT to facilitate immediate internal fixation. The
results of this study demonstrated that the studied treat-
ment protocol provides a promising alternative for man-
aging these complex open elbow injuries. Neuromuscular
patients who lack bowel and bladder control risk seeding
a wound with feces or urine and development of decubiti
lead to an infection by direct contamination. A persistent
cerebrospinal fluid leak after surgery may interfere with
wound healing and is a favorable medium for bacterial
growth. Poor personal hygiene and soiling of the wound
also may be factors [2]. The first few hours after tissue is
contaminated by bacteria constitute a critical period du-
ring which wound infections are established. Therefore,
per operative factors influence the incidence of infections,
even though infections are typically not detected until
some days after surgery. The factors that influence the in-
cidence of surgical-wound infection include complexity of
surgery, the patient’s underlying illness, poor local blood
and oxygen supply, or damage to the vasculature. If one of
these complicating factors occurs, these wounds can be
considered potentially problematic wounds with an ex-
tended healing time. In these cases, more specific care is
needed [13-15]. Based on these literature data, we thought
that per operative HBO support might reduce the inci-
dence of infection and wound healing problems in our
patients.
All wounds disrupt the local vascular supply as a result
of injury and thrombosis of vessels, which cause wounds
to be hypoxic when compared with normal tissue. Re-
sistance to infection therefore, depends on the partial
pressure of oxygen in the wound and can thus poten-
tially be improved by increasing the arterial oxygen
tension beyond that required to saturate blood. The
therapeutic effect of HBO treatment with regard to in-
fections is mainly attributable to reduction of hypoxia in
tissues with significant improvement in leukocyte andphagocyte killing capacity [9,16]. Healing is impaired at
low oxygen tensions which are often observed in wounds
[17]. Cells such as neutrophils, fibroblasts, macrophages,
osteoclasts and osteoblasts are all dependent upon an
environment in which oxygen is not deficient in order to
carry out their specific anti-infectious, inflammatory or
repair functions [16]. Oxygen has for a long time been
used in clinical practice to enhance wound healing. Sys-
temic administration of oxygen through the lung and
the cardiovascular system, however, is known to improve
wound healing and decrease the risk of infection. Hopf
et al. used supplemental oxygen in surgical patients and
found that supplementary oxygen in the inspired air for
the first 2 postoperative days has reduced the postopera-
tive wound infection rate after colorectal surgery. Sup-
plementary oxygen treatment should (from their point
of view) be a standard procedure for the treatment of all
colorectal patients [13,18].
Animal experiments using microelectrodes to measure
oxygen partial pressures in normal, healing, and infected
tissues and in tissues containing foreign material have
demonstrated marked hypoxia, especially when infected
foreign material was present [19]. HBO therapy can
greatly increase the oxygen concentration in all body tis-
sues by hyper oxygenation. It also decreases lesion-tissue
edema through vasoconstriction, and resists superim-
posed infection via an improvement in white blood cell
phagocytosis and antibiotic synergy. Thus it was added
to immediate internal fixation and early soft-tissue
coverage to refine clinical results [9,13,20,21].
The removal of spinal implants at an early postopera-
tive stage can compromise fusion and curve correction.
As such, retention of implants should be one of the
goals when treating infection. Buchowski et al. [22]
reported that 39.1% of patients with spinal deformity
and postoperative infections required instrumentation
removal. In the study by Ho et al. [23] implant removal
was necessary in 10 of the 53 patients with postoperative
infections after spinal deformity surgery. The incidence
of pseudarthrosis in subjects with an infection was 25%
(13 of 51). Larrson et al. [9] reported a consecutive series
of six children with neuromuscular spine deformity who
received HBO as an adjunct in the management of post-
operative deep infection after complex correction sur-
gery. The spinal implants remained intact without any
bone healing problems or radiological signs of loosening.
In our series, two of five patients who had infection re-
quired implant removal. One had infection in addition
to implant prominence which resulted in repeated skin
breakdown and the other had an infection which per-
sisted despite serial irrigation and debridement. In the
remaining 3 patients, HBO was added to the treatment
and these recovered without any need for implant re-
moval. These support the results of Larsson et al. [9].
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ment we found that the 3 patients with HBOT recovered.
One of the patients which required implant removal had
persistent pseudoarthrosis.
Significant blood loss, use of allograft, increased num-
ber of fused levels, lenghtened operation time have all
been cited as potential risk factors for infection in pa-
tients with neuromuscular scoliosis [1-3,24]. One of the
strong points of our study is that both groups are similar
in terms of surgical technique (blood loss, use of allo-
graft, fused levels, operation time) and post operative
treatment regimen as all patients were operated by the
same surgeon. Elimination of the variability of these in-
fection risk factors further amplifies the effect of HBO
treatment.
There are several limitations to this study. The study
was limited in that it was conducted in a retrospective
fashion. Also, a direct comparison of final outcomes in
patients with infection who undergo P-HBO versus who
receive standard prophylaxis is complicated by several
factors. Even in patients with similar co morbidities, the
local and systemic factors that hinder infection cure and
wound healing vary greatly between individuals [20]. It
is possible that those undergoing HBOT had closer sur-
veillance and more detailed nursing care than those who
did not. Finally, the small sample size of this case series
makes it difficult to stratify the risk factors in the pa-
tients, which would be useful for evaluating the efficacy
of HBO prophylaxis.Conclusion
This work describes an alternative prophylaxis protocol
with promising preliminary results for managing wound
care after neuromuscular deformity surgery. HBO is a
safe and potentially useful supplement to prevent post-
operative deep infections in complex spine deformity in
high risk neuromuscular patients. Additional prospective
studies are needed to further substantiate the effective-
ness of this method in reducing postoperative spinal sur-
gical site infections.Consent
Written informed consent was obtained from the patient
for publication of Figure 1 images.
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